Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Young adults are largely self-initiating GLP-1 weight-loss drugs, influenced by family, TikTok, and Instagram — not their doctors. A qualitative study of 25 adults aged 18–29 in South Florida found that 3 in 4 sought the drugs themselves, and none recalled any clinical counseling before starting. Many sourced the drugs from med spas, telehealth apps, or online sellers, sometimes without a prescription.
A new qualitative study out of Florida International University sheds light on how young adults aged 18–29 are navigating the path to GLP-1 weight-loss medications — and it's a route that often bypasses traditional clinical care entirely. Of 25 participants interviewed, 19 sought the drugs themselves rather than receiving a clinician's recommendation. Motivations ranged from medical conditions like polycystic ovary syndrome to appearance goals, with family members and social media platforms like TikTok and Instagram playing a major role in sparking interest.
Perhaps most striking: not a single participant recalled a healthcare provider discussing expectations, risks, or monitoring before they started treatment. Many sourced the drugs outside conventional care — through med spas, telehealth apps, or online sellers requiring no prescription — and most paid out of pocket after insurance denials.
Key Takeaways:
Why it matters: As GLP-1 use surges among young adults, a clear counseling gap has emerged. Clinicians need to engage proactively with this population — covering dosing, side effects, long-term expectations, and reproductive considerations — before patients turn to unregulated sources for both information and the drugs themselves.
